Tijtgat, J.; Calliauw, E.; Dirven, I.; Vounckx, M.; Kamel, R.; Vanbinst, A.M.; Everaert, H.; Seynaeve, L.; Van Den Berge, D.; Duerinck, J.;
et al. Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series. Cancers 2023, 15, 2560.
https://doi.org/10.3390/cancers15092560
AMA Style
Tijtgat J, Calliauw E, Dirven I, Vounckx M, Kamel R, Vanbinst AM, Everaert H, Seynaeve L, Van Den Berge D, Duerinck J,
et al. Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series. Cancers. 2023; 15(9):2560.
https://doi.org/10.3390/cancers15092560
Chicago/Turabian Style
Tijtgat, Jens, Evan Calliauw, Iris Dirven, Manon Vounckx, Randa Kamel, Anne Marie Vanbinst, Hendrik Everaert, Laura Seynaeve, Dirk Van Den Berge, Johnny Duerinck,
and et al. 2023. "Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series" Cancers 15, no. 9: 2560.
https://doi.org/10.3390/cancers15092560
APA Style
Tijtgat, J., Calliauw, E., Dirven, I., Vounckx, M., Kamel, R., Vanbinst, A. M., Everaert, H., Seynaeve, L., Van Den Berge, D., Duerinck, J., & Neyns, B.
(2023). Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series. Cancers, 15(9), 2560.
https://doi.org/10.3390/cancers15092560
